Abstract:Objective:To evaluate the efficacy and the related factors of percutaneous transluminal renal angioplasty (PTRA) for pediatric renovascular hypertension (RVH) by a systematic review and meta-analysis.Methods:A systematic search was performed on international and domestic databases (Pubmed, Excerpt Medical Database (EMBASE), Cochrane library, Clinical trial.gov, Medline, China Biology Medicine (CBM), China national knowledge infrastructure (CNKI), VIP database and Wanfang) which included studies on PTRA for pediatric RVH from the establishment of the databases to March 2019. Key words of "pediatric" "children" "renal artery stenosis" "renovascular hypertension" "angioplasty" and "intervention" were used. Meta-analysis was made on the rate of technical success, clinical blood pressure improvement, complication and restenosis of PTRA as well as the predictors of its efficacy. The data consolidation, analysis of heterogeneity and sensitivity, and publication bias were performed using Comprehensive meta analyst and Open meta analyst software.Results:Seventeen observational non-controlled studies comprising 384 patients with RVH who underwent PTRA were identified. The technical success rate of PTRA was 93.9% (95% confidence interval ( CI) 89.3%-97.5%). The improvement rate of blood pressure was 68.4% (95% CI 57.2%-78.7%), and the cure rate was 40.0% (95% CI 25.0%-55.8%). The subsequent subgroup analysis showed that there was no significant difference in the improvement rate of blood pressure after PTRA among the patients with RVH caused by fibromuscular dysplasia, Takayasu arteritis and neurofibromatosis type 1, respectively ( P>0.05). The improvement rate of blood pressure in patients with combined lesions in renal artery branches was significantly lower than that in patients with lesions only in main renal artery ( RR=1.659, 95% CI 1.023-2.689, P=0.040). It was found that 25.5% (95% CI 19.3%-32.2%) of patients required repeat procedure because of restenosis of lesions. Procedural complication of PTRA occurred in 8.3% (95% CI 3.5%-14.4%) of patients. In terms of clinical blood pressure improvement rate after PTRA, there was heterogeneity among the enrolled studies, but the results of meta-analysis were robust with low risk of publication bias ( t=1.690, 95% CI -0.363-3.124, P=0.110). Conclusion:The result of the Meta-analysis suggests that PTRA may provide a safe and effective treatment for pediatric RVH, and patients with stenosis of renal arterial branches are associated with relatively poor clinical outcomes.

Percutaneous Transluminal Renal Angioplasty Attenuates Poststenotic Kidney Mitochondrial Damage In Pigs With Renal Artery Stenosis And Metabolic Syndrome

Renal Revascularization Attenuates Myocardial Mitochondrial Damage and Improves Diastolic Function in Pigs with Metabolic Syndrome and Renovascular Hypertension

Coexisting Renal Artery Stenosis and Metabolic Syndrome Magnifies Mitochondrial Damage, Aggravating Poststenotic Kidney Injury in Pigs.

A Mitochondrial Permeability Transition Pore Inhibitor Improves Renal Outcomes after Revascularization in Experimental Atherosclerotic Renal Artery Stenosis

Adipose Tissue‐Derived Mesenchymal Stem Cells Improve Revascularization Outcomes to Restore Renal Function in Swine Atherosclerotic Renal Artery Stenosis

Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis

Diabetes Insipidus-Like State Complicating Percutaneous Transluminal Renal Stenting for Transplant Renal Artery Stenosis.

Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease

Renal Ischemia Alters Expression of Mitochondria-Related Genes and Impairs Mitochondrial Structure and Function in Swine Scattered Tubular-Like Cells

Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles Elicit Better Preservation of the Intra-Renal Microvasculature Than Renal Revascularization in Pigs with Renovascular Disease

Abstract 063: Urinary Mitochondrial DNA Copy Number Identifies Renal Mitochondrial Injury in Renovascular Hypertensive Patients Undergoing Renal Revascularization

Endovascular revascularization for the treatment of renal artery stenosis

Changes in Glomerular Filtration Rate after Renal Revascularization Correlate with Microvascular Hemodynamics and Inflammation in Swine Renal Artery Stenosis.

Endothelial Outgrowth Cells Shift Macrophage Phenotype and Improve Kidney Viability in Swine Renal Artery Stenosis

Mesenchymal Stem/stromal Cells and Their Extracellular Vesicle Progeny Decrease Injury in Post-Stenotic Swine Kidney Through Different Mechanisms.

Endovascular Management of Transplant Renal Artery Stenosis: A Single-Center Retrospective Study

In High Risk Hypertensive Subjects with Incidental and Unilateral Renal Artery Stenosis Percutaneous Revascularization with Stent Improves Blood Pressure Control but Not Glomerular Filtration Rate

P0146MESENCHYMAL STEM CELLS AND THEIR EXTRACELLULAR VESICLES PROGENY DECREASE RENAL INJURY IN EXPERIMENTAL SWINE RENAL ARTERY STENOSIS THROUGH DIFFERENT MECHANISMS

Angiotensin Receptor Blockade Has Protective Effects on the Post-Stenotic Porcine Kidney

Renovascular Hypertension Induces Myocardial Mitochondrial Damage, Contributing to Cardiac Injury and Dysfunction in Pigs with Metabolic Syndrome

Efficacy of Percutaneous Transluminal Renal Angioplasty for Pediatric Renovascular Hypertension: a Meta-Analysis